NAV

$ 17.81

NAV Day Change

17.81 | 2
%
As of 04/14/2014 | USD

Yield

--

Load

None

Total Assets

430.3 mil

Expenses

1.00%

Fee Level

Below Average

Turnover

88%

Status

Open

Min. Inv.

--

52-Week Range

Category

Health

Investment Style

Large Growth

Loading ...

iehsx Quote

iehsx Price Today

iehsx Price History

NAV iehsx

Net Asset Value iehsx

Day Change iehsx

Yield iehsx

Category iehsx

Investment Style iehsx

Load iehsx

Expenses Ratio iehsx

Turnover iehsx

Minimum Investment iehsx

1 year range iehsx

52 weeek range iehsx

Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar Quote

Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar Price

Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar Price Today

Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar Price History

NAV Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

Net Asset Value Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

Day Change Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

Yield Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

Category Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

Investment Style Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

Load Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

Expenses Ratio Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

Turnover Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

Minimum Investment Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

1 year range Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

52 weeek range Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar

Top Holdings  IEHSX More...

Top Holdings IEHSX

Johnson & Johnson , Celgene Corporation , AbbVie Inc , Gilead Sciences Inc , Pfizer Inc ,

Top Sectors  IEHSX More...

Top Sectors IEHSX

Healthcare
Technology
Consumer Cyclical
Basic Materials

Dividend and Capital Gains Distributions  IEHSX

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc.

Sponsor Center

Analysis  iehsx - ING BlackRock Health Sciences Opp S More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!
Mutual Fund Quote: iehsx ING BlackRock Health Sciences Opp S - Morningstar
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title

Previous: easax - EAS Crow Point Alternatives A  |  Next: gxicx - Goldman Sachs Income Strategies C